Dennis Busse

Essen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications

Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Effect of riociguat on right ventricular function in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: January 06, 2021

Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.

Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: September 24, 2020

Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study.

Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study.

Journal: Pulmonary circulation
Published: July 31, 2020

Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies.

Effect of riociguat on pulmonary arterial compliance in the PATENT and CHEST studies.

Journal: Pulmonary circulation
Published: November 05, 2019

Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE.

Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE.

Journal: International journal of cardiology
Published: September 13, 2019

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies).

Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies).

Journal: Pulmonary circulation
Published: August 05, 2019

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.

Journal: The European respiratory journal
Published: October 19, 2018

REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.

REVEAL risk score in patients with chronic thromboembolic pulmonary hypertension receiving riociguat.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: July 14, 2017

REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival.

REVEAL risk scores applied to riociguat-treated patients in PATENT-2: Impact of changes in risk score on survival.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
Published: July 14, 2017

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors.

RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors.

Journal: The European respiratory journal
Published: December 09, 2016
Showing 1-10 of 10

Last Updated: 09/26/2026